Assistant Professor

As a dual-trained pharmacologist and veterinarian I have a passion for translational medicine and therapeutic development. I apply this expertise towards studying the pathobiology of inflammatory bowel disease (IBD), with the ultimate goal of developing mechanistically novel IBD therapeutics. My laboratory uses colitis models to characterize pathways involved in inflammation and pain in IBD, with validation of all findings in human patient samples. We employ molecular pharmacology to interrogate pathways critical to colitis initiation and progression, and work closely with Johns Hopkins Drug Discovery (JHDD) to develop rationally-designed small molecule drugs targeting pathways of interest.